Coppell Advisory Solutions’s AbbVie ABBV Stock Holding History

Coppell Advisory Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$368K	Sell	585 -2,935	-83%	-$631K	0.03%	347
2026 Q1	$750K	Buy	3,520 +247	+8%	+$54.8K	0.44%	24
2025 Q4	$752K	Buy	3,273 +45	+1%	+$10.3K	0.07%	201
2025 Q3	$720K	Buy	3,228 +129	+4%	+$26.3K	0.08%	201
2025 Q2	$565K	Buy	3,099 +243	+9%	+$45.2K	0.07%	224
2025 Q1	$553K	Buy	2,856 +1,244	+77%	+$242K	0.08%	200
2024 Q4	$284K	Buy	1,612 +40	+3%	+$7.35K	0.04%	225
2024 Q3	$306K	Sell	1,572 -734	-32%	-$137K	0.05%	215
2024 Q2	$396K	Buy	+2,306	New	+$382K	0.07%	176
2023 Q4	$313K	Buy	2,018 +1,128	+127%	+$164K	0.06%	199
2023 Q3	$144K	Sell	890 -364	-29%	-$53.4K	0.05%	184
2023 Q2	$167K	Sell	1,254 -385	-23%	-$56.5K	0.05%	208
2023 Q1	$259K	Sell	1,639 -141	-8%	-$21.6K	0.08%	174
2022 Q4	$288K	Buy	+1,780	New	+$273K	0.1%	143

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Coppell Advisory Solutions's ABBV Position: Q2 2026 in Review

Coppell Advisory Solutions reduced its AbbVie (ABBV) stake by 83% in Q2 2026, selling an estimated $631K and leaving 585 shares worth $368K. The position accounts for 0.03% of the portfolio, ranked #347.

Coppell Advisory Solutions first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $752K in Q4 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Coppell Advisory Solutions held 585 shares of AbbVie worth $368K as of Q2 2026.
Coppell Advisory Solutions sold 2,935 AbbVie shares in Q2 2026, an estimated $631K.
AbbVie made up 0.03% of Coppell Advisory Solutions's portfolio in Q2 2026, its #347 holding.
Coppell Advisory Solutions first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Coppell Advisory Solutions's AbbVie position peaked at $752K in Q4 2025.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Coppell Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.